Clicky

Veru Inc.(VERU) News

Date Title
Oct 9 Veru Inc (VERU) Q3 2024 Earnings Call Highlights: Strategic Cost Management and Revenue Growth ...
Aug 8 Veru Inc. (VERU) Reports Q3 Loss, Tops Revenue Estimates
Aug 8 Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results
Jul 29 Veru to Participate in the BTIG Virtual Biotechnology Conference
Jun 24 Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American Diabetes Association's 84th Scientific Sessions
Jun 18 Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024
Jun 17 Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Shareholders
Jun 10 Veru to Present at the American Diabetes Association's 84th Scientific Sessions
May 15 Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss
May 14 Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week
May 9 Veru Inc (VERU) Q2 2024 Earnings Call Transcript Highlights: Strategic Focus and Financial Recovery
May 8 Veru Inc. (VERU) Fiscal 2024 Q2 Earnings: Clinical Advances Amid Financial Strains
May 8 Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program
May 2 Veru to Present at the GLP-1 Based Therapeutics Summit
May 1 Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
Apr 30 Veru Inc. (VERU) Just Flashed Golden Cross Signal: Do You Buy?
Apr 30 Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
Apr 25 Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11
Apr 17 What Makes Veru (VERU) a New Buy Stock
Apr 1 Veru Announces Date of 2024 Annual Meeting of Shareholders